Serological and molecular analysis of hepatitis C virus envelope regions 1 and 2 during acute and chronic infections in chimpanzees

Journal of Medical Virology

Volumn 52, Issue 4, 1997, Pages 441-450

  Van Doorn, Leen Jan ^a,e   Van Hoek, Kitty ^a   De Martinoff, Guy ^b   Bosman, Fons ^b   Stuyver, Lieven ^b   Kos, Ton ^c   Frantzen, Inge ^d   Sillekens, Peter ^d   Maertens, Geert ^b   Quint, Wim ^a  

^a Delft Diagnostic Laboratory   (Netherlands)

^b INNOGENETICS   (Belgium)

^c Dutch Primate Center   (Netherlands)

^d Organon Teknika   (Netherlands)

^e Delft Diagnostic Laboratory   (Netherlands)

Author keywords

Long term follow up; Quantitative HCV RNA; Sequence evolution

Indexed keywords

LIVER ENZYME; VIRUS ENVELOPE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHIMPANZEE; CHRONIC HEPATITIS; GENETIC VARIABILITY; HEPATITIS C VIRUS; HEPATITIS NON A NON B; NONHUMAN; VIREMIA; VIRUS ENVELOPE; VIRUS GENE; VIRUS INFECTIVITY; VIRUS REACTIVATION;

ACUTE DISEASE; ANIMALS; BASE SEQUENCE; CHRONIC DISEASE; CLONING, MOLECULAR; DNA PRIMERS; EVOLUTION, MOLECULAR; FEMALE; HEPACIVIRUS; HEPATITIS C; MALE; PAN TROGLODYTES; PHYLOGENY; POLYMERASE CHAIN REACTION; RNA, VIRAL; VIRAL ENVELOPE PROTEINS; VIREMIA;

ANIMALIA; HEPATITIS C VIRUS; NON-A, NON-B HEPATITIS VIRUS; PAN (APE); PAN TROGLODYTES;

EID: 0030844348     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199708)52:4<441::AID-JMV17>3.0.CO;2-J     Document Type: Article

References (39)

1. Beach MJ, Meeks EL, Mimms LT, Vallari D, DuCharme L, Spelbring J, Taskar S, Schleicher JB, Krawczynski K, Bradley DW (1992): Temporal relationships of hepatitis C virus RNA and antibody responses following experimental infection of chimpanzees. Journal of Medical Virology 36:226-237.
2. Boom R, Sol CJA, Salimans MMM, Jansen CL, Wertheim-van Dillen PME, van der Noordaa J (1990): Rapid and simple method for purification of nucleic acids. Journal of Clinical Microbiology 28: 495-503.
3. Chien DY, Choo QL, Ralston R, Spaete R, Tong M, Houghton M (1993): Persistence of HCV despite antibodies to both putative envelope glycoproteins. Lancet 342:933.
4. Choo Q-L, Richman KH, Han JH, Berger K, Lee C, Dong C, Gallegos C, Coit D, Medina-Selby A, Barr PJ, Weiner AJ, Bradley DW, Kuo G, Houghton M (1991): Genetic organization and diversity of the hepatitis C virus. Proceedings of the National Academy of Sciences USA 99:2451-2455.
5. Choo Q-L, Kuo G, Ralston R, Weiner A, Chien D, Van Nest G, Han J, Berger K, Thudium K, Kuo C, Kansopon J, McFarland J, Tabrizi A, Ching K, Moss B, Cummins LB, Houghton M, Muchmore E (1994): Vaccination of chimpanzees against infection by the hepatitis C virus. Proceedings of the National Academy of Sciences USA 91:1294-1298.
6. Diepolder H, Zachoval R, Hoffman RM, Wierenga EA, Santantonio T, Jung MC, Eichenlaub D, Pape GR (1995): Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 346: 1006-1007.
7. Farci P, Alter HJ, Govindarajan S, Wong DC, Engle R, Lesniewski RR, Mushahwar IK, Desai SM, Miller RH, Ogata N, Purcell RH (1992): Lack of protective immunity against reinfection with hepatitis C virus. Science 258:135-140.
8. Farci P, Alter HJ, Wong DC, Miller RH, Govindarajan S, Engle R, Shapiro M, Purcell RH (1994): Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proceedings of the National Academy of Sciences USA 19:7792-7796.
9. Felstenstein J (1993): PHYLIP: Phylogeny Inference Package, version 3.5c. Seattle, WA: Univ. of Washington.
10. Gretch D, Corey L, Wilson J, dela Rosa C, Willson R, Carithers R, Busch M, Hart J, Sayers M, Han J (1994): Assessment of hepatitis C virus RNA levels by quantitative competitive RNA polymerase chain reaction: High-titer viremia correlates with advanced stage of disease. Journal of Infectious Diseases 169:1219-1225.
11. Hagiwara H, Hayashi N, Mita E, Naito M, Kasahara A, Fusamoto H, Kamada T (1993): Quantitation of hepatitis C virus RNA in serum of asymptomatic blood donors and patients with type C chronic liver disease. Hepatology 17:545-550.
12. Kato N, Yokosuka O, Hosoda K, Ito Y, Ohto M, Omata M (1993): Quantification of Hepatitis C virus by competitive reverse transcription-polymerase chain reaction: increase of the virus in advanced liver disease. Hepatology 18(1):16-20.
13. Kato N, Ootsuyama Y, Sekiya H, Ohkoshi S, Nakazawa T, Hijikata M, Shimotohno K (1994): Genetic drift in hypervariable region 1 of the viral genome in persistent hepatitis C virus infection. Journal of Virology 68(8):4776-4784.
14. Koziel MJ, Dudley D, Wong JT, Dienstag J, Houghton M, Ralston R, Walker BD (1992): Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. Journal of Immunology 149:3339-3344.
15. Maekewa S, Enomoto N, Kurosaki M, Marumo F, Sato C (1995): Host dependent variation of hepatitis C virus phylogenetic analyses. Archives of Virology 140:2123-2133.
16. Maertens G, Stuyver L (1996): Genotypes and genetic variation of hepatitis C virus. In Zuckerman A, Harrison T (eds): "Molecular Medicine of Hepatitis Molecular Medical Science series." Chichester: John Wiley & Sons, pp 183-234.
17. Maertens G, Ducatteeuw A, Stuyver L, Vandeponseele P, Venneman A, Wyseur A, Bosman F, Heijtink RA, de Martinoff G (1994): Low prevalence of anti-E1 antibodies reactive to recombinant type 1b E1 envelop protein in type 2, 3, and 4 sera, but high prevalence in subtypes 1a and 1b. In Nishioka K, Suzuki H, Mishiro S, Oda T (eds): "Viral Hepatitis and Liver Disease." Tokyo: Springer Verlag Tokyo, pp 314-316.
18. Maertens G, Ducatteeuw A, Barlet V, Zarksi JP, de Martinoff G, Bosman F, Stuyver L, Brouwer JT, Heijtink RA (1995): E1 Antibody level monitoring predicts long-term resolution of hepatitis C virus infection. Hepatology 22:355A.
19. Ogata N, Alter HJ, Miller RH, Purcell RH (1991): Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proceedings of the National Academy of Sciences USA 88:3392-3396.
20. Okamoto H, Mishiro S (1994): Genetic heterogeneity of hepatitis C virus. Intervirology 37:68-76.
21. Okamoto H, Kojima M, Okada S-I, Yoshizawa H, Iizuka H, Tanaka T, Muchmore E, Peterson DA, Mishiro S (1992): Genetic drift of hepatitis C virus during an 8.2-year infection in a chimpanzee: Variability and stability. Virology 190:894-899.
22. Sällberg M, Ruden U, Wahren B, Magnius LO (1993): Antigenic region within the hepatitis C virus envelope 1 and non-structural proteins: identification of an IgG3-restricted recognition site within the envelope 1 protein. Clinical and Experimental Immunology 91:489-494.
23. Sekiya H, Kato N, Ootsuyama Y, Nakazawa T, Yamaguchi K, Shimotohno K (1994): Genetic alteration of the putative envelope proteins encoding region of the hepatitis C virus in the progression to relapsed phase from acute hepatitis: humoral immune response to hypervariable region 1. International Journal of Cancer 57:664-670.
24. Shimizu YK, Weiner AJ, Rosenblatt J, Wong DC, Shapiro M, Popkin T, Houghton M, Alter HJ, Purcell RH (1990): Early events in hepatitis C virus infection of chimpanzees. Proceedings of the National Academy of Sciences USA 87:6441-6444.
25. Sillekens P, Kok W, van Gemen B, Lens P, Huisman H, Cuypers Th, Kievits T (1994): Specific detection of HCV RNA using NASBA as a diagnostic tool. In "Hepatitis C Virus GEMHEP." Paris: John Libbey Eurotext, pp 71-82. (ed. Groupe Francais d'Etudes Moleculaire des Hepatitis)
26. Simmonds P (1995): Variability of Hepatitis C virus. Hepatology 21: 570-583.
27. Stuyver L, van Arnhem W, Wyseur A, Hernandez F, Delaporte E, Maertens G (1994): Classification of hepatitis C viruses based on phylogenetic analysis of the envelope 1 and nonstructural 5B regions and identification of five additional subtypes. Proceedings of the National Academy of Sciences USA 91:10134-10138.
28. Tsiquaye KN, Bird RG, Tovey G, Wyke RJ, Williams R, Zuckerman AJ (1980): Further evidence of cellular changes associated with non-A, non-B hepatitis. Journal of Medical Virology 5:63-71.
29. Vandamme A-M, Van Dooren S, Kok W, Goubau P, Fransen K, Kievits T, Schmit J-C, De Clercq E, Desmeyter J (1995): Detection of HIV-1 RNA in plasma and serum samples using the NASBA amplification system compared to RNA-PCR. Journal of Virological Methods 52:121-132.
30. Van Doom LJ, Quint W, Tsiquaye K, Voermans J, Paelinck D, Kos T, Maertens G, Schellekens H, Murray K (1994): Longitudinal analysis of hepatitis C virus infection and genetic drift of the hypervariable region. Journal of Infectious Diseases 169:1226-1235.
31. Van Doom LJ, Capriles I, Maertens G, DeLeys R, Murray K, Kos T, Schellekens H, Quint WGV (1995): Sequence evolution of the hypervariable region in the putative envelope region E2/NS1 of hepatitis C virus is correlated with specific humoral immune responses. Journal of Virology 69(2):773-778.
32. Van Gemen B, Kievits T, Romano J (1995a): Transcription based nucleic acid amplification methods like NASBA and 3SR applied to viral diagnosis. Reviews in Medical Virology 5:205-211.
33. Van Gemen B, van der Wiel P, van Beuningen R, Sillekens P, Jurriaans S, Dries C, Schoones R, Kievits T (1995b): The one-tube quantitative HIV-1 RNA NASBA: precision, accuracy, and application. PCR Methods and Applications 4:S177-S184.
34. Weiner AJ, Geysen HM, Christopherson C, Hall JE, Mason TJ, Saracco G, Bonino F, Crawford K, Marion CD, Crawford KA, Brunetto M, Barr PJ, Miyamura T, McHutchinson J, Houghton M (1992): Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: Potential role in chronic HCV infections. Proceedings of the National Academy of Sciences USA 89:3468-3472.
35. Weiner AJ, Erickson AL, Kansopon J, Crawford K, Muchmore E, Hughes AL, Houghton M, Walker CM (1995): Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant. Proceedings of the National Academy of Sciences USA 92:2755-2759.
36. Yamaguchi K, Tanaka E, Higashi K, Kiyosawa K, Matsumoto A, Furuta S, Hasegawa A, Tanaka S, Kohara M (1994): Adaptation of hepatitis C virus for persistent infection in patients with acute hepatitis. Gastroenterology 106:1344-1348.
37. Zaaijer HL, Cuypers HThM, Reesink HW, Winkel IN, Gerken G, Lelie PN (1993): Reliability of polymerase chain reaction for detection of hepatitis C virus. Lancet 341:722-724.
38. Zaaijer HL, Vallari DS, Cunningham M, Lesniewski R, Reesink HW, van der Poel CL, Lelie PN (1994): E2 and NS5: new antigens for detection of hepatitis C virus antibodies. Journal of Medical Virology 44:395-397.
39. Zibert A, Schreier E, Roggendorf M (1995): Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment. Virology 208:653-661.